↓ Skip to main content

American Association for Cancer Research

Article Metrics

Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas

Overview of attention for article published in Molecular Cancer Therapeutics, July 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#32 of 3,373)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
11 news outlets
blogs
1 blog
twitter
11 tweeters

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
28 Mendeley
Title
Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas
Published in
Molecular Cancer Therapeutics, July 2020
DOI 10.1158/1535-7163.mct-19-0958
Pubmed ID
Authors

Mara Gilardi, Zhiyong Wang, Marco Proietto, Anastasia Chillà, Juan Luis Calleja-Valera, Yusuke Goto, Marco Vanoni, Matthew R. Janes, Zbigniew Mikulski, Antonio Gualberto, Alfredo A. Molinolo, Napoleone Ferrara, J. Silvio Gutkind, Francis Burrows

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 29%
Researcher 7 25%
Student > Bachelor 2 7%
Other 1 4%
Student > Master 1 4%
Other 2 7%
Unknown 7 25%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 32%
Medicine and Dentistry 5 18%
Agricultural and Biological Sciences 2 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Chemistry 2 7%
Other 2 7%
Unknown 6 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 89. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2021.
All research outputs
#307,603
of 18,881,749 outputs
Outputs from Molecular Cancer Therapeutics
#32
of 3,373 outputs
Outputs of similar age
#10,736
of 305,522 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#1
of 46 outputs
Altmetric has tracked 18,881,749 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,373 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 305,522 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.